Live Streaming
Program Highlight
Company Profile
-
font size
decrease font size
increase font size
A new drug developed by UK scientists to treat Covid-19 patients is being trialed at University Hospital Southampton. Developed by UK biotech company Synairgen, it uses a protein called interferon beta, which our bodies produce when we get a viral infection. Initial results from the trial are expected by the end of June. There are currently few effective treatments for coronavirus with doctors relying on patients' immune systems//bbc
Published in
International News
Latest from nuke
- Cyberattacks cost British businesses $55 billion in past five years, broker says
- Existential challenge': Plastic pollution treaty talks begin
- Indonesia has 574 conservation areas dominated by nature reserves
- Global powers must honor Indonesia's sovereignty
- Indonesia lobbies Saudi Arabia for additional Hajj officers’ quota